Vanguard Group’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $671M | Buy |
35,430,016
+481,231
| +1% | +$8.92M | 0.01% | 880 |
|
|
2025
Q3 | $651M | Buy |
34,948,785
+179,670
| +0.5% | +$3.36M | 0.01% | 911 |
|
|
2025
Q2 | $641M | Sell |
34,769,115
-83,444
| -0.2% | -$1.48M | 0.01% | 886 |
|
|
2025
Q1 | $609M | Sell |
34,852,559
-138,597
| -0.4% | -$2.34M | 0.01% | 885 |
|
|
2024
Q4 | $606M | Buy |
34,991,156
+68,346
| +0.2% | +$1.25M | 0.01% | 924 |
|
|
2024
Q3 | $650M | Buy |
34,922,810
+482,191
| +1% | +$8.13M | 0.01% | 881 |
|
|
2024
Q2 | $530M | Sell |
34,440,619
-531,992
| -2% | -$7.6M | 0.01% | 957 |
|
|
2024
Q1 | $517M | Buy |
34,972,611
+838,654
| +2% | +$11.6M | 0.01% | 989 |
|
|
2023
Q4 | $487M | Sell |
34,133,957
-176,802
| -0.5% | -$2.51M | 0.01% | 985 |
|
|
2023
Q3 | $478M | Sell |
34,310,759
-31,098
| -0.1% | -$398K | 0.01% | 917 |
|
|
2023
Q2 | $404M | Sell |
34,341,857
-1,214,228
| -3% | -$13.8M | 0.01% | 1052 |
|
|
2023
Q1 | $409M | Buy |
35,556,085
+120,252
| +0.3% | +$1.49M | 0.01% | 1021 |
|
|
2022
Q4 | $440M | Sell |
35,435,833
-93,213
| -0.3% | -$1.19M | 0.01% | 954 |
|
|
2022
Q3 | $466M | Sell |
35,529,046
-361,147
| -1% | -$5.34M | 0.01% | 879 |
|
|
2022
Q2 | $501M | Sell |
35,890,193
-427,096
| -1% | -$5.71M | 0.01% | 858 |
|
|
2022
Q1 | $541M | Buy |
36,317,289
+859,548
| +2% | +$11.8M | 0.01% | 911 |
|
|
2021
Q4 | $480M | Buy |
35,457,741
+1,200,707
| +4% | +$17M | 0.01% | 1023 |
|
|
2021
Q3 | $504M | Buy |
34,257,034
+388,742
| +1% | +$6.57M | 0.01% | 970 |
|
|
2021
Q2 | $616M | Buy |
33,868,292
+1,003,809
| +3% | +$17.9M | 0.02% | 860 |
|
|
2021
Q1 | $571M | Buy |
32,864,483
+494,439
| +2% | +$8.69M | 0.02% | 878 |
|
|
2020
Q4 | $562M | Buy |
32,370,044
+485,276
| +2% | +$7.74M | 0.02% | 822 |
|
|
2020
Q3 | $440M | Sell |
31,884,768
-1,162,198
| -4% | -$17.1M | 0.01% | 834 |
|
|
2020
Q2 | $477M | Buy |
33,046,966
+648,716
| +2% | +$8.53M | 0.02% | 786 |
|
|
2020
Q1 | $354M | Buy |
32,398,250
+1,336,678
| +4% | +$24.6M | 0.02% | 827 |
|
|
2019
Q4 | $663M | Buy |
31,061,572
+1,673,924
| +6% | +$37.5M | 0.02% | 684 |
|
|
2019
Q3 | $675M | Buy |
29,387,648
+1,451,948
| +5% | +$31M | 0.03% | 657 |
|
|
2019
Q2 | $550M | Buy |
27,935,700
+440,936
| +2% | +$8.59M | 0.02% | 752 |
|
|
2019
Q1 | $535M | Buy |
27,494,764
+182,856
| +0.7% | +$3.46M | 0.02% | 749 |
|
|
2018
Q4 | $450M | Buy |
27,311,908
+1,149,082
| +4% | +$23.1M | 0.02% | 755 |
|
|
2018
Q3 | $605M | Buy |
26,162,826
+173,363
| +0.7% | +$3.93M | 0.02% | 700 |
|
|
2018
Q2 | $565M | Sell |
25,989,463
-1,188,113
| -4% | -$23.2M | 0.02% | 709 |
|
|
2018
Q1 | $480M | Sell |
27,177,576
-3,636,112
| -12% | -$64.1M | 0.02% | 773 |
|
|
2017
Q4 | $578M | Buy |
30,813,688
+359,139
| +1% | +$7.14M | 0.03% | 692 |
|
|
2017
Q3 | $668M | Buy |
30,454,549
+17,224,990
| +130% | +$389M | 0.03% | 601 |
|
|
2017
Q2 | $319M | Buy |
13,229,559
+797,491
| +6% | +$20.3M | 0.02% | 943 |
|
|
2017
Q1 | $347M | Buy |
12,432,068
+734,489
| +6% | +$19.3M | 0.02% | 856 |
|
|
2016
Q4 | $286M | Buy |
11,697,579
+917,510
| +9% | +$21M | 0.02% | 939 |
|
|
2016
Q3 | $271M | Buy |
10,780,069
+528,214
| +5% | +$12.7M | 0.02% | 903 |
|
|
2016
Q2 | $212M | Buy |
10,251,855
+302,868
| +3% | +$6.31M | 0.01% | 1023 |
|
|
2016
Q1 | $200M | Buy |
9,948,987
+393,778
| +4% | +$7.55M | 0.01% | 1035 |
|
|
2015
Q4 | $193M | Buy |
9,555,209
+217,065
| +2% | +$4.57M | 0.01% | 1032 |
|
|
2015
Q3 | $216M | Buy |
9,338,144
+98,499
| +1% | +$2.51M | 0.02% | 953 |
|
|
2015
Q2 | $238M | Buy |
9,239,645
+1,036,254
| +13% | +$29.4M | 0.02% | 950 |
|
|
2015
Q1 | $272M | Buy |
8,203,391
+579,782
| +8% | +$18.8M | 0.02% | 868 |
|
|
2014
Q4 | $232M | Buy |
7,623,609
+266,415
| +4% | +$7.34M | 0.02% | 885 |
|
|
2014
Q3 | $179M | Buy |
7,357,194
+816,708
| +12% | +$22.6M | 0.01% | 1000 |
|
|
2014
Q2 | $188M | Buy |
6,540,486
+1,196,874
| +22% | +$34.8M | 0.01% | 1001 |
|
|
2014
Q1 | $149M | Buy |
5,343,612
+282,288
| +6% | +$7.75M | 0.01% | 1095 |
|
|
2013
Q4 | $132M | Buy |
5,061,324
+179,990
| +4% | +$4.64M | 0.01% | 1138 |
|
|
2013
Q3 | $112M | Buy |
4,881,334
+81,223
| +2% | +$2M | 0.01% | 1163 |
|
|
2013
Q2 | $125M | Buy |
+4,800,111
| New | +$139M | 0.01% | 1022 |
|
Other funds holding SBRA
N
EGM
LIMS
Vanguard Group's SBRA Position: Q4 2025 in Review
Vanguard Group increased its Sabra Healthcare REIT (SBRA) stake by 1.4% in Q4 2025, buying an estimated $8.92M and bringing the position to 35,430,016 shares worth $671M. The position accounts for 0.01% of the portfolio, ranked #880.
Vanguard Group first reported a position in SBRA in Q2 2013 and has held it in 51 quarters since. The position peaked at $675M in Q3 2019. 439 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.
- Vanguard Group held 35,430,016 shares of Sabra Healthcare REIT worth $671M as of Q4 2025.
- Vanguard Group bought 481,231 Sabra Healthcare REIT shares in Q4 2025, an estimated $8.92M.
- Sabra Healthcare REIT made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #880 holding.
- Vanguard Group first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Sabra Healthcare REIT position peaked at $675M in Q3 2019.
- 439 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.